Daniel Keating is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where his practice primarily focuses on corporate and securities matters, including sophisticated domestic and international transactions. He is also a member of the firm’s global generic pharmaceutical industry group.

Dan has more than 20 years of legal experience. He has represented clients in mergers and acquisitions, public offerings, and financings, as well as related corporate governance matters. In particular, Dan has substantial experience representing multinational companies on cross-border M&A deals and complex commercial transactions. Dan’s clients include companies across a diverse range of industries, including technology, fintech, financial, pharmaceutical, and life sciences.